3rd Quarter - Report
WILLIAMS AND JENSEN, PLLC for GENENTECH INC
Client
Income
$30,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Payment policies for prescription drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Taxation/Internal Revenue Code TAX
General tax issues and tax extenders
| Lobbyist | Covered position, as disclosed |
|---|---|
| REBECCA ANDERSON | — |
| CHRISTOPHER W HATCHER | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Health Issues HCR
Issues concerning clinical trials. General health care reform (Patient Protection and Affordable Care Act). Congressional oversight issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| KARINA LYNCH | — |
| ROBERT J MARTINEZ New | — |
| GEORGE OLSEN | — |
| JOYCE A ROGERS | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ROCHE HOLDINGS LTD. | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.